All that is known right now, he wrote, is that Tarceva works better than a sugar pill given with supportive care--meaning patients don't get other cancer drugs they otherwise might receive, such as Taxotere from Aventis (nyse: AVE - news - people ) and Iressa, a similar pill from AstraZeneca (nyse: AZN - news - people ).